Are peptides a Stripe restricted business?
Effectively yes — peptide sales fall under Stripe's pseudo-pharmaceutical and unverified-health-claim restrictions. Where the line runs, why 'research use only' does not help, and what the alternatives are.
Verdict: effectively restricted. Peptides sold to consumers sit in Stripe’s pseudo-pharmaceutical territory — unapproved substances plus health claims — and accounts in this category get suspended at review, not at signup.
The source. Stripe’s restricted businesses list restricts pseudo-pharmaceuticals and products making health claims without regulatory approval. Injectable and oral peptides sold outside the prescription channel are unapproved drugs in the FDA’s framing — which is exactly the category the restriction describes, whatever the storefront calls them.
Where the line actually runs
The verdict depends on what is sold and what is claimed, not on the word “peptide”:
| Product | Category as a reviewer sees it | Processable? |
|---|---|---|
| Injectable/oral peptides sold to consumers | Unapproved drug / pseudo-pharmaceutical | No — restricted |
| Same products labeled “research use only” on a consumer storefront | Same, with a known evasion pattern attached | No — and the label itself is a flag |
| Genuine reagent supply to institutions (invoiced B2B, verification, no consumer checkout) | Laboratory supply | Sometimes — underwriting decides, not the label |
| Peptide-ingredient cosmetics, topical | Cosmetics | Generally yes |
| Supplements with structure/function claims only | Nutraceutical | Generally yes, claims-dependent |
The “research use only” row deserves emphasis because it is the most common question. The disclaimer changes nothing about how the transaction pattern looks: consumer checkout, retail quantities, bodybuilding-adjacent marketing. Risk teams classify by that pattern.
How these accounts actually end
Peptide merchants routinely process on Stripe for a while — onboarding does not read your catalog. The account ends the way category-violation accounts end (the full sequence is in the restricted businesses guide):
- A trigger — content review, a dispute spike, a card-network sweep of the category.
- Suspension with funds held, typically when volume has become meaningful.
- A review in which the product catalog itself is the finding; there is no wording fix for an unapproved-substance verdict.
The practical cost is not the lost account — it is the held balance and the MATCH-list exposure that shortens the life of every subsequent mainstream account.
If you sell adjacent products
For cosmetics, supplements, or genuine lab supply, the risk is being mistaken for the restricted category. Your public pages decide that:
- State the product category explicitly (cosmetic, dietary supplement, laboratory reagent) and the intended use.
- Strip disease-treatment claims — “supports recovery” survives review; “heals injuries” does not.
- For B2B reagent supply: institutional ordering, quote flows, and account verification visible on the site separate you from consumer RUO storefronts.
Run the free scan to see whether your current pages read as the category you think you are in.
If consumer peptides are the business
High-risk specialist processors underwrite the category knowingly — with reserves, catalog review, and pricing to match. That is the honest path; descriptor games and serial mainstream accounts are not, and the industry-wide matched-merchant lists make that route strictly worse over time.
Frequently asked
- My peptides are labeled 'research use only' — does that make them processable?
- No. The RUO label is treated by risk teams as a known workaround for consumer sales of unapproved substances. If the site sells to the public, reviewers assume human consumption regardless of labeling.
- Are supplements restricted too?
- Conventional supplements are processable when marketed without disease-treatment claims. The restriction concentrates on unapproved substances and on health claims a regulator would challenge.
- What about peptide skincare?
- Topical cosmetic products containing peptide ingredients are cosmetics, not pseudo-pharmaceuticals, and are generally processable with standard cosmetic marketing claims.
- Which processors accept peptide vendors?
- High-risk specialists that explicitly underwrite nutraceuticals and research chemicals. Expect reserves, higher rates, and product-list review at onboarding.